Treating Hodgkin lymphoma with Immunotherapy

Like many types of cancer, Hodgkin lymphoma (HL) continues to present a challenge for medical practitioners and researchers. Although considered treatable, its aggressive tendency to relapse makes it trickier to manage than its more common counterpart—non-Hodgkin lymphoma (NHL). However, the health sciences are determined to not lose in the race as even now, experts are looking to immunotherapy as a possible weapon against HL.

What is Hodgkin lymphoma?

It is one of the two most common types of lymphoma along with NHL, although the latter occurs in more patients. Like NHL, HL also begins as a mutated lymphocyte which, instead of …read more